Sellas Life Sciences Group Inc (SLS) is down Friday morning, with the stock declining -2.88% in pre-market trading to 1.01. SLS's short-term technical score of 9 indicates that the stock has traded less bullishly over the last month than 91% of stocks on the market. In the Biotechnology industry, which ranks 122 out of 146 industries, the stock ranks higher than 17% of stocks. Sellas Life Sciences Group Inc has risen 7.22% over the past month, closing at $0.96 on November 3. During this period of time, the stock fell as low as $0.88 and as high as $1.31. SLS has an average analyst recommendation of Strong Buy. The company has an average price target of $5.33.
SLS has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on SLS!